AIDS Research and Treatment

Research Article

Morbidity and Mortality Patterns of Hospitalised Adult HIV/AIDS Patients in the Era of Highly Active Antiretroviral Therapy: A 4-year Retrospective Review from Zaria, Northern Nigeria

Table 5

Comparisons of demographic and clinical variables in relation to survival outcome of HIV/AIDS patients.


Variables	Survival status		value
Variables	Died	Survived

Age in years
Median (IQR)	38 (30, 46)	35 (30, 45)	0.29 (NS)
Gender ( %)
Male	42 (38.5%)	67 (61.5%)	0.03
Female	24 (24.5%)	74 (75.5%)	0.03
Symptom duration in days—
Median (IQR)	60 (15, 120)	30 (14, 90)	0.018
Hospital stay in days
Median (IQR)	7 (3, 18)	17 (10, 31)	0.0001
PCV
Median (IQR)	22 (16, 29)	28 (20, 35)	0.012
Platelets count
Median (IQR)	129 (85, 252)	242 (186, 312)	0.016
CD4 cell count
Median (IQR)	45 (21, 237)	140 (60, 194)	0.18 (NS)
ART duration (yrs)
Median (IQR)	0.25 (0.17, 3.0)	0.8 (0.28, 2.0)	0.67 (NS)

NB—NS: not significant; PCV: packed cell volume; IQR: interquartile range.